[1] 朱峰,易正辉,赵静,等.二甲双胍对精神科肥胖患者糖脂代谢的影响[J].临床精神医学杂志,2011,21(3):171~173. [2] 张玉胜,贾继敏,张玉香,等.二甲双胍联合运动疗法对抗精神病药致糖脂代谢紊乱患者血抵抗素和脂联素水平的影响[J].中国医药,2014,9(4):502~505. [3] 高兰,王高华,刘浩,等.氯氮平联合二甲双胍对SD大鼠空腹血糖及胰岛GLUT2表达水平的影响[J].上海精神医学,2013,25(3):149~156. [4] 中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版(精神障碍分类)[J].中华精神科杂志,2001,34(3):184~188. [5] Cheng-Hung Lee,Ming-Jer Hsieh,Shang-Hung Chang,et al.Enhancement of diabetic wound repair using biodegradable nanofibrous metformin-eluting membranes:in vitro and in vivo[J].ACS applied materials&interfaces,2014,6(6):3979~3986. [6] 董介正,徐莲莲,刘义,等.二甲双胍对奥氮平及喹硫平所致大鼠糖脂代谢紊乱的防治作用[J].中国药理学与毒理学杂志,2014,28(3):362~366. [7] 戴升太,朱立毛,肖依烂,等.二甲双胍对抗精神病药所致精神分裂症患者肥胖及糖脂代谢的影响[J].临床精神医学杂志,2014,(6):409~410. [8] 高兰,王高华.二甲双胍对抗非典型抗精神病药物引起糖脂代谢异常的研究现状[J].临床精神医学杂志,2014,24(1):67~68. [9] Yeager CA,Winsberg B,Hobbs B,et al.Weight-reducing effects of metformin are sustained over 40 weeks for psychiatric inpatients receiving polypharmacy[J].Journal of clinical psychopharmacology,2011,31(4):546~547. [10] 胡孝芬,欧阳泽祥.二甲双胍对奥氮平致体质量增加的精神分裂症患者血清同型半胱氨酸水平的影响[J].中国健康心理学杂志,2013,21(11):1610~1612. [11] Hasnain M,Fredrickson SK,Vieweg WV,et al.Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs[J].Journal of psychopharmacology,2011,25(6):715~721. [12] 张跃坤,翟天一,赵丽琼,等.二甲双胍对氯氮平血药浓度及疗效的影响[J].现代预防医学,2012,39(6):1578~1579. [13] Zhu Y,Feng Y,Shen L,et al.Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry(UPLC-TOF/MS)[J].Journal of chromatography,B.Analytical technologies in the biomedical and life sciences,2013,925:110~116.
2018, Vol. 24 
冀公网安备13080202000677号